Rebecca Taub

CIK 1423898 · Pres., R&D, and CMO · last filed 2026-03-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$532.57M

Companies

2

Total Filings

29

Lifetime Open-Market Net

-$47.03M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MDGL Director 1,107,753 $480.77 $532.57M -$47.04M 27 2026-03-06
VIA Pharmaceuticals, Inc. (VIAP) Delisted SVP, Research & Development 32,500 $9.8K 2 2008-12-19

Recent Filings · Page 3 of 3

29 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-07-11 MDGL Grant (A) $0 EDGAR
2019-03-11 MDGL Grant (A) $0 EDGAR
2018-06-12 MDGL Sell (S) +73,526 $21.14M EDGAR
2018-03-05 MDGL Grant (A) $0 EDGAR
2017-03-06 MDGL Grant (A) $0 EDGAR
2016-08-23 MDGL Grant (A) +30,626 $0 EDGAR
2016-07-26 MDGL Grant (A) +1,161,938 $0 EDGAR
2008-12-19 VIA Pharmaceuticals, Inc. (VIAP) Delisted Mixed +157,500 $9.8K EDGAR
2008-01-16 VIA Pharmaceuticals, Inc. (VIAP) Delisted Grant (A) $0 EDGAR
Showing 2129 of 29
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.